Artesunate alleviates hypoxic-ischemic brain damage in neonatal rats by inhibiting NLRP3 inflammasome activation and inflammatory cytokine secretion.
- Author:
Yinli CAO
1
;
Yazhou SUN
2
;
Qingyang CUI
2
;
Xiaojing HE
2
;
Zhenzhen LI
2
Author Information
1. Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453000, China. *Corresponding author, E-mail: xxyxy2006@163.com.
2. Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453000, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Rats;
Animals, Newborn;
Artesunate/pharmacology*;
Brain/metabolism*;
Caspases/metabolism*;
Dexamethasone;
Hypoxia-Ischemia, Brain/pathology*;
Inflammasomes;
Interleukin-6/metabolism*;
NLR Family, Pyrin Domain-Containing 3 Protein/metabolism*;
Rats, Sprague-Dawley;
Tumor Necrosis Factor-alpha/metabolism*;
Water/metabolism*
- From:
Chinese Journal of Cellular and Molecular Immunology
2023;39(5):410-415
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the protective effect of artesunate on hypoxic-ischemic brain damage (HIBD) and its mechanism in neonatal rats. Methods 7-day-old neonatal SD rats were randomly divided into sham operation group, model group, artesunate 5 mg/kg group, artesunate 10 mg/kg group, artesunate 20 mg/kg group and dexamethasone 6 mg/kg group, with 18 rats in each group. HIBD models were established in groups except for the sham operation group. The sham operation group only needed to separate the left common carotid artery without ligation and nitrogen-oxygen mixed gas ventilation. Each group was injected with drug intraperitoneally right after surgery and the rats in the sham operation group and the model group were injected with an equal volume of normal saline (once a day for a total of 5 times). One hour after the last injection, the rats in each group were scored for neurological defects. After the rats were sacrificed, the brain water content was measured and the pathological changes of the brain tissues of rats were observed. Terminal-deoxynucleotidyl transferase mediated nick end labeling (TUNEL) was used to detect the neuronal cell apoptosis, and ELISA was applied to detect the levels of IL-1β, IL-6 and TNF-α in brain tissues and peripheral blood of each group of rats. Western blot analysis was adopted to detect the protein expression levels of NLR family pyrin domain containing 3 (NLRP3), apoptosis-associated speck-like protein containing CARD (ASC) and caspase-1 in the rats brain tissues of each group. Results Compared with the model group, the neurological deficit score was decreased; the pathological damage of brain tissues was relieved; the brain water content was significantly reduced; the apoptosis number of hippocampal neurons was decreased significantly; the levels of IL-1β, IL-6 and TNF-α in brain tissues and peripheral blood were significantly reduced; the protein expression levels of NLRP3, ASC and caspase-1 were significantly lowered in the middle-dose and high-dose artesunate groups and the dexamethasone group. Conclusion Artesunate can improve the neurological function, relieve the brain damage, and alleviate the brain edema in neonatal rats with HIBD. It can protect the HIBD, which may be related to the inhibition of NLRP3 inflammasome activation and reduction of inflammatory cytokine secretion.
